Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06879925

Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19

The goal of this clinical trial is to determine whether Qi-Gong can improve physiological function and quality of life (QoL) in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC).

Study Objectives:

To assess whether Qi-Gong improves physiological function in individuals with PASC.

To evaluate whether Qi-Gong enhances quality of life in individuals with PASC.

Study Design:

If a comparison group is included, researchers will compare Qi-Gong with standard care to assess its effectiveness.

Participant Involvement:

Practice Qi-Gong three times per week for three months. Record physiological data monthly.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

PASC Post Acute Sequelae of COVID 19 COVID-19 Chronic Disease Coronaviridae Infections Coronavirus Infections Disease Attributes Infections Lung Diseases Nidovirales Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral Post-Acute COVID-19 Syndrome Post-Infectious Disorders RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

20 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Renhe nursing home, New Taipei City, Taiwan

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • PASC
  • above 20 y/o

Exclusion criteria

  • Those who cannot cooperate
  • Severe schizophrenia

Treatment and study plan

QI-GONG and control

Behavioral

QIGONG

Primary outcomes

  1. Pulmonary Function Test (Forced vital capacity)

    Time frame: From enrollment to the end of treatment at 12 weeks

    FVC，over 80% is better

  2. Pulmonary Function Test (FEV1)

    Time frame: From enrollment to the end of treatment at 12 weeks

    FEV1，over 80% is better

  3. Pulmonary Function Test (FVCFEV1)

    Time frame: From enrollment to the end of treatment at 12 weeks

    FVCFEV1，over 80% is better

  4. Heart rate variability

    Time frame: From enrollment to the end of treatment at 12 weeks

    Low Frequency,40%-60%

  5. Heart rate variability

    Time frame: From enrollment to the end of treatment at 12 weeks

    High Frequency,40%-60%

  6. Heart rate variability

    Time frame: From enrollment to the end of treatment at 12 weeks

    LF/HF,0.6-2.5

  7. Heart rate variability

    Time frame: From enrollment to the end of treatment at 12 weeks

    Heart rate variability ,25ms-70ms

  8. Quality of Life(The short version of the World Health Organization Quality of Life ，WHOQOL-BREF)

    Time frame: From enrollment to the end of treatment at 12 weeks

    WHOQOL-BREF 4 domains,and each one score is 4 - 20. more score more better

Study contacts

Contact information is provided by the study sponsor or research team.

Po-Chi Wu

CONTACT

[email protected]

+886900622739

Sponsors and collaborators

Lead sponsor

POCHIWU

Other

Registry information

Official study title

The Effects of Qi-gong on Physiology and Quality of Life in Patients with Post-acute Sequelae of Covid-19

Acronym: QG-PASC

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Mar 17, 2025
Registry last updated
Mar 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.